| May 11, 2008 |
| Press Releases |
| |
| May 11, 2008 |
| Phosphatonins – basic science and clinical aspects |
| Rajiv Kumar, Rochester, USA |
| |
| Klotho as a regulator of fibroblast growth factor signalling and phosphate/calcium metabolism |
| Makoto Kuro-o, Dallas, USA |
| |
| New elements in the role of ureamic toxins in arteriosclerosis |
| Raymond Vanholder, Ghent, Belgium |
| |
| Obesity as risk factor for CKD |
| Stephan J. L. Bakker, Groningen, Netherlands |
| |
| Who and how should we screen for CKD in the elderly population? |
| Ron Gansevoort, Groningen, Netherlands |
| |
| IgA nephropathy |
| John Feehally, Leicester, UK |
| |
| |
| May 12, 2008 |
| Guidelines for reporting observational studies: the newly published STROBE statement |
| Carmine Zoccali, Reggio Calabria, Italy |
| |
| Who and how to screen for CKD? |
| Stein Hallan, Trondheim, Norway |
| |
| |
| May 13, 2008 |
| Revascularisation for atherosclerotic renovascular disease: results of the ASTRAL trial |
| Philip Kalra, Salford, UK |
| |